Pedone T, Aldag E, Pedersen R, Besur S, Safdar K, Sahajpal A. Evaluation of the Impact of the Implementation of a Specialty Pharmacy Program in the Treatment of Hepatitis C (HCV). Poster presented at: Aurora Scientific Day; May 25, 2016; Milwaukee, WI.
Poster presented at: Aurora Scientific Day; May 25, 2016; Milwaukee, WI.
Conclusion: SVR (sustained virologic response) rates are comparable to clinical trials in this real-life clinical setting using a specialty pharmacy program. Those with HCV Genotype 1A had lower SVR rates post-medication completion, though it did not reach statistical significance. There was no difference in SVR rates between previously treated and treatment-naive patients.